October 25, 2017 — ViewRay Inc. announced outcomes data presented during the recent 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego. This data highlighted compelling early results using the company's magnetic resonance imaging (MRI)-guided MRIdian radiation therapy system for the treatment of inoperable, locally advanced pancreatic cancer.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now